Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renvela in Hyperphosphatemic CKD Patients (TOSCANA)
NCT02332811Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2013
- Primary completion
- Jul 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevelamer carbonate in hyperphosphatemia, sponsored by Sanofi. Started Oct 2013; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT02332811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332811.